NBIX logo

Neurocrine Biosciences (NBIX) Total assets

annual total assets:

$3.72B+$467.30M(+14.37%)
December 31, 2024

Summary

  • As of today (May 24, 2025), NBIX annual total assets is $3.72 billion, with the most recent change of +$467.30 million (+14.37%) on December 31, 2024.
  • During the last 3 years, NBIX annual total assets has risen by +$1.65 billion (+79.43%).
  • NBIX annual total assets is now at all-time high.

Performance

NBIX Total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

quarterly total assets:

$3.69B-$31.00M(-0.83%)
March 31, 2025

Summary

  • As of today (May 24, 2025), NBIX quarterly total assets is $3.69 billion, with the most recent change of -$31.00 million (-0.83%) on March 31, 2025.
  • Over the past year, NBIX quarterly total assets has increased by +$215.30 million (+6.20%).
  • NBIX quarterly total assets is now -0.83% below its all-time high of $3.72 billion, reached on December 31, 2024.

Performance

NBIX quarterly total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

Total assets Formula

Total Assets = Current Assets + Non-Current Assets

NBIX Total assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+14.4%+6.2%
3 y3 years+79.4%+72.0%
5 y5 years+184.7%+170.8%

NBIX Total assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+79.4%-0.8%+83.9%
5 y5-yearat high+184.7%-0.8%+170.8%
alltimeall timeat high+5151.1%-0.8%>+9999.0%

NBIX Total assets History

DateAnnualQuarterly
Mar 2025
-
$3.69B(-0.8%)
Dec 2024
$3.72B(+14.4%)
$3.72B(+5.2%)
Sep 2024
-
$3.54B(+7.0%)
Jun 2024
-
$3.31B(-4.8%)
Mar 2024
-
$3.47B(+6.8%)
Dec 2023
$3.25B(+37.3%)
$3.25B(+14.2%)
Sep 2023
-
$2.85B(+9.0%)
Jun 2023
-
$2.61B(+10.7%)
Mar 2023
-
$2.36B(-0.4%)
Dec 2022
$2.37B(+14.3%)
$2.37B(+10.5%)
Sep 2022
-
$2.14B(+6.9%)
Jun 2022
-
$2.01B(-6.5%)
Mar 2022
-
$2.14B(+3.5%)
Dec 2021
$2.07B(+19.5%)
$2.07B(+2.7%)
Sep 2021
-
$2.02B(+3.1%)
Jun 2021
-
$1.96B(+6.0%)
Mar 2021
-
$1.85B(+6.4%)
Dec 2020
$1.73B(+32.8%)
$1.73B(+15.4%)
Sep 2020
-
$1.50B(-0.9%)
Jun 2020
-
$1.52B(+11.3%)
Mar 2020
-
$1.36B(+4.3%)
Dec 2019
$1.31B(+31.5%)
$1.31B(+10.7%)
Sep 2019
-
$1.18B(+10.6%)
Jun 2019
-
$1.07B(+11.4%)
Mar 2019
-
$957.72M(-3.6%)
Dec 2018
$993.15M(+21.5%)
$993.15M(+6.4%)
Sep 2018
-
$933.75M(+11.0%)
Jun 2018
-
$841.32M(+4.3%)
Mar 2018
-
$806.36M(-1.4%)
Dec 2017
$817.59M(+123.9%)
$817.59M(+5.8%)
Sep 2017
-
$772.50M(+2.4%)
Jun 2017
-
$754.09M(+160.6%)
Mar 2017
-
$289.36M(-20.7%)
Dec 2016
$365.09M(-23.1%)
$365.09M(-8.5%)
Sep 2016
-
$399.16M(-7.1%)
Jun 2016
-
$429.84M(-6.4%)
Mar 2016
-
$459.33M(-3.3%)
Dec 2015
$474.79M(+95.4%)
$474.79M(-3.6%)
Sep 2015
-
$492.44M(-3.7%)
Jun 2015
-
$511.20M(-3.1%)
Mar 2015
-
$527.78M(+117.2%)
Dec 2014
$243.03M(+57.1%)
$243.03M(-5.7%)
Sep 2014
-
$257.75M(-4.4%)
Jun 2014
-
$269.54M(-3.5%)
Mar 2014
-
$279.30M(+80.6%)
Dec 2013
$154.68M(-21.1%)
$154.68M(-6.8%)
Sep 2013
-
$165.97M(-5.1%)
Jun 2013
-
$174.81M(-5.0%)
Mar 2013
-
$183.92M(-6.2%)
Dec 2012
$195.98M(+41.6%)
$195.98M(+1.4%)
Sep 2012
-
$193.25M(-4.4%)
Jun 2012
-
$202.09M(-3.8%)
Mar 2012
-
$210.14M(+51.9%)
Dec 2011
$138.37M(-4.2%)
$138.37M(-7.2%)
Sep 2011
-
$149.03M(+17.0%)
Jun 2011
-
$127.41M(-4.9%)
Mar 2011
-
$134.00M(-7.2%)
Dec 2010
$144.42M
$144.42M(-3.7%)
DateAnnualQuarterly
Sep 2010
-
$149.93M(-3.3%)
Jun 2010
-
$155.04M(+94.1%)
Mar 2010
-
$79.88M(+12.8%)
Dec 2009
$70.82M(-40.1%)
$70.82M(-6.7%)
Sep 2009
-
$75.91M(-12.6%)
Jun 2009
-
$86.87M(-14.0%)
Mar 2009
-
$101.03M(-14.5%)
Dec 2008
$118.18M(-57.3%)
$118.18M(-43.1%)
Sep 2008
-
$207.73M(-7.9%)
Jun 2008
-
$225.67M(-7.5%)
Mar 2008
-
$243.88M(-11.8%)
Dec 2007
$276.65M(-29.0%)
$276.65M(-12.9%)
Sep 2007
-
$317.50M(-7.1%)
Jun 2007
-
$341.86M(-6.0%)
Mar 2007
-
$363.71M(-6.7%)
Dec 2006
$389.68M(-19.3%)
$389.68M(-3.6%)
Sep 2006
-
$404.13M(-8.7%)
Jun 2006
-
$442.54M(-7.3%)
Mar 2006
-
$477.40M(-1.2%)
Dec 2005
$483.12M(-7.0%)
$483.12M(-3.6%)
Sep 2005
-
$500.97M(+5.4%)
Jun 2005
-
$475.51M(-2.2%)
Mar 2005
-
$486.37M(-6.3%)
Dec 2004
$519.22M(-6.4%)
$519.22M(-6.0%)
Sep 2004
-
$552.62M(+1.1%)
Jun 2004
-
$546.48M(-5.3%)
Mar 2004
-
$577.27M(+4.0%)
Dec 2003
$554.96M(+108.2%)
$554.96M(+0.5%)
Sep 2003
-
$552.40M(+48.2%)
Jun 2003
-
$372.76M(+2.7%)
Mar 2003
-
$363.04M(+36.2%)
Dec 2002
$266.54M(-23.0%)
$266.54M(-10.7%)
Sep 2002
-
$298.64M(-4.1%)
Jun 2002
-
$311.37M(-5.2%)
Mar 2002
-
$328.29M(-5.2%)
Dec 2001
$346.35M(+86.2%)
$346.35M(+94.6%)
Sep 2001
-
$177.95M(+8.8%)
Jun 2001
-
$163.62M(-5.3%)
Mar 2001
-
$172.84M(-7.1%)
Dec 2000
$185.96M(+70.3%)
$185.96M(+93.2%)
Sep 2000
-
$96.26M(-1.7%)
Jun 2000
-
$97.91M(-8.0%)
Mar 2000
-
$106.40M(-2.6%)
Dec 1999
$109.20M(+35.7%)
$109.20M(+59.9%)
Sep 1999
-
$68.30M(-3.3%)
Jun 1999
-
$70.60M(-5.4%)
Mar 1999
-
$74.60M(-7.3%)
Dec 1998
$80.50M(-12.4%)
$80.50M(-7.4%)
Sep 1998
-
$86.90M(+4.1%)
Jun 1998
-
$83.50M(-5.4%)
Mar 1998
-
$88.30M(-3.9%)
Dec 1997
$91.90M(+17.8%)
$91.90M(+8.2%)
Sep 1997
-
$84.90M(+1.1%)
Jun 1997
-
$84.00M(+1.3%)
Mar 1997
-
$82.90M(+6.3%)
Dec 1996
$78.00M
$78.00M(+8.0%)
Sep 1996
-
$72.20M(-1.6%)
Jun 1996
-
$73.40M(+161.2%)
Mar 1996
-
$28.10M

FAQ

  • What is Neurocrine Biosciences annual total assets?
  • What is the all time high annual total assets for Neurocrine Biosciences?
  • What is Neurocrine Biosciences annual total assets year-on-year change?
  • What is Neurocrine Biosciences quarterly total assets?
  • What is the all time high quarterly total assets for Neurocrine Biosciences?
  • What is Neurocrine Biosciences quarterly total assets year-on-year change?

What is Neurocrine Biosciences annual total assets?

The current annual total assets of NBIX is $3.72B

What is the all time high annual total assets for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual total assets is $3.72B

What is Neurocrine Biosciences annual total assets year-on-year change?

Over the past year, NBIX annual total assets has changed by +$467.30M (+14.37%)

What is Neurocrine Biosciences quarterly total assets?

The current quarterly total assets of NBIX is $3.69B

What is the all time high quarterly total assets for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly total assets is $3.72B

What is Neurocrine Biosciences quarterly total assets year-on-year change?

Over the past year, NBIX quarterly total assets has changed by +$215.30M (+6.20%)
On this page